Andreas Argyrides
Stock Analyst at Oppenheimer
(1.95)
# 1241
Out of 5,370 analysts
112
Total ratings
47.83%
Success rate
26.55%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KALA Kala Bio | Assumes: Outperform | 15 | 4.37 | 243.25% | 1 | Jun 2, 2025 | |
HRMY Harmony Biosciences ... | Assumes: Outperform | 61 | 32.74 | 86.32% | 1 | Jun 2, 2025 | |
AQST Aquestive Therapeuti... | Assumes: Outperform | 15 7 | 3.44 | 103.49% | 5 | Jun 2, 2025 | |
ABEO Abeona Therapeutics | Assumes: Outperform | 19 | 5.96 | 218.79% | 1 | Jun 2, 2025 | |
DYN Dyne Therapeutics | Assumes: Outperform | 60 34 | 11.49 | 195.91% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 3 | 0.77 | 289.61% | 2 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 13 | 14.07 | -7.6% | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 4 | 0.55 | 627.27% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 90 | 13 | 592.31% | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 9 | 1.92 | 368.75% | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 15 | 13.57 | 10.54% | 8 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 181 181 | 177.4 | 2.03% | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 2.8 | 828.57% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 15.62 | 124.07% | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 7 7 | 8.2 | -14.63% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 104 | 42.51 | 144.65% | 14 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 0.8 | 525% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | 1.29 | 597.67% | 7 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 19 19 | 14.89 | 27.6% | 9 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 29 29 | 19.27 | 50.49% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 21 21 | 9.1 | 130.77% | 4 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 224 224 | 22.65 | 888.96% | 4 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 57 57 | 24.33 | 134.28% | 2 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 6 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 7 | 0.81 | 764.2% | 3 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 3.77 | 165.25% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 10 | n/a | n/a | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 73 70 | 55.87 | 25.29% | 6 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 42 | n/a | n/a | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Aug 8, 2022 |